Kathleen Isabel Pritchard, C.M.
Toronto, Ontario
Kathleen Pritchard is an internationally renowned oncologist whose work has been at the forefront of treatments for women with early stage breast cancer. Professor emerita at the University of Toronto and a senior scientist at the Sunnybrook Research Institute, she is a prominent leader in clinical trials of adjuvant and hormonal therapy. Her studies have helped predict cancer recurrence and reduce breast cancer mortality rates. A well-known fixture on scientific advisory boards and data monitoring committees, she mentors oncologists in Canada and abroad.